7 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Innovative anti-influenza drugs excluding viral escape (ANTIFLU)
Date du début: 1 juin 2011, Date de fin: 31 mai 2016,
ANTIFLU is to develop innovative drugs against influenza virus infections based on a novelconcept that precludes the development of viral resistance and ensures efficacy againstupcoming pandemic influenza strains. Viral replication is known to depend on multiple hostfactors. Whilst traditional anti-influenza treatments usually target viral factors, ANTIFLU willaim at drugs interfering with host-re ...
Voir le projet
11
Participants partenaires
TERMINÉ
Systems biology of Mycobacterium tuberculosis (SYSTEMTB)
Date du début: 1 avr. 2010, Date de fin: 30 sept. 2014,
Tuberculosis (TB) is a re-emerging global health threat caused by Mycobacterium tuberculosis (Mtb). One third of the world's population is infected with Mtb and new infections occur at a rate of one per second. Despite global research efforts, mechanisms underlying pathogenesis, virulence and persistence of Mtb infection remain poorly understood. Simple reductionist approaches are insufficient to ...
Voir le projet
14
Participants partenaires
TERMINÉ
European Initiative for basic research in Microbiology and Infectious Diseases (EIMID ITN)
Date du début: 1 oct. 2010, Date de fin: 30 sept. 2014,
The overall objective of EIMID-ITN is to train ten early stage researchers to join the next generation of world experts in the biology of infectious diseases and specifically in the mechanisms of host-pathogen interaction. The project will be carried out within the highly successful European collaboration EIMID (European Initiative for Basic Research in Microbiology and Infectious Diseases) that b ...
Voir le projet
6
Participants partenaires
TERMINÉ
Discovery and preclinical development of new generation tuberculosis vaccines (NEWTBVAC)
Date du début: 1 janv. 2010, Date de fin: 28 févr. 2014,
"With 14.4 million prevalent cases and 1.7 million deaths tuberculosis (TB) remains one of the most serious infectious diseases to date. An estimated 2 billion people are believed to be infected with Mycobacterium tuberculosis and at risk of developing disease. Multi- and extensively drug resistant strains are increasingly appearing in many parts of the world, including Europe. While with current ...
Voir le projet
39
Participants partenaires
TERMINÉ
Poverty related Diseases College(International Programme on BioMedicine and Development) (PRD COLLEGE)
Date du début: 1 juil. 2009, Date de fin: 31 mars 2013,
"To bridge the gap between the biological sciences, health and development in Africa, a consortium is created and named the PRD College, which proposes to reorganise and educate young African and European scientists to perform research, on poverty related and neglected diseases (PR&ND) that is relevant to development. These diseases are common ground for both the African nations who wish to deve ...
Voir le projet
10
Participants partenaires
TERMINÉ
New Approaches to Target Tuberculosis (NATT)
Date du début: 1 oct. 2008, Date de fin: 30 sept. 2011,
"The increasing emergence of multidrug resistant strains and extensively drug resistant strains, the last one being virtually untreatable, urgently demand novel drugs for therapy of tuberculosis. This project has the aim of bringing together a number of research scientists with expertise in a broad range of disciplines, both from Europe and from India, covering the development field from chemistry ...
Voir le projet
8
Participants partenaires
TERMINÉ
Mycobacterium tuberculosis W-Beijing genetic diversity and differential virulence and host immune responses (TB-VIR)
Date du début: 1 avr. 2008, Date de fin: 31 mars 2011,
"Improvements in TB control require the development of new tools for rapid and accurate diagnosis and intervention. This development is likely to benefit from more detailed knowledge of microbe-host relationships during infection. Following M. tuberculosis infection, only 5-10% of immunocompetent individuals develop TB. It is increasingly thought that the virulence of the infecting strain, togethe ...
Voir le projet